# FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study

> **NCT03490201** · NA · COMPLETED · sponsor: **Abbott Medical Devices** · enrollment: 592 (actual)

## Conditions studied

- Ventricular Tachycardia

## Interventions

- **DEVICE:** Market Approved RF Ablation System
- **DEVICE:** FlexAbility SE Ablation Catheter

## Key facts

- **NCT ID:** NCT03490201
- **Lead sponsor:** Abbott Medical Devices
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-06-01
- **Primary completion:** 2024-04-11
- **Final completion:** 2024-04-11
- **Target enrollment:** 592 (ACTUAL)
- **Last updated:** 2025-01-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03490201

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03490201, "FLExAbility Sensor Enabled Substrate Targeted Ablation for the Reduction of VT Study". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT03490201. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*